Entering text into the input field will update the search result below

Evoke Pharma announces positive findings from second GIMOTI market research study

  • Evoke Pharma (NASDAQ:EVOK) announces positive findings from a second market research study conducted for GIMOTI (metoclopramide) nasal spray.
  • The study aimed to gather further market insights on perception of GIMOTI in the GI community.
  • In May 2021, Evoke’s commercialization partner, EVERSANA, conducted the GIMOTI

Recommended For You

About EVOK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EVOK--
Evoke Pharma, Inc.